Imatinib (Gleevec/Glivec)

Imatinib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imatinib (Gleevec/Glivec), covering 2009-02-13 to 2009-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib [Phase 4]